| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
84,190,000 |
| Market
Cap: |
10.39(B) |
| Last
Volume: |
427,350 |
Avg
Vol: |
426,179 |
| 52
Week Range: |
$67.31 - $141.53 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 983 |
| Guru Rank Value : 0 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Sarepta Therapeutics is a commercial-stage biopharmaceutical company focused on helping patients through the discovery and development of RNA-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. Co. is developing therapeutic candidates for a range of diseases and disorders, including Duchenne muscular dystrophy, Limb-girdle muscular dystrophies and other neuromuscular and central nervous system related disorders. Co.'s commercial product, EXONDYS 51® (eteplirsen) Injection is indicated for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
143,757 |
247,027 |
| Total Buy Value |
$0 |
$0 |
$13,295,068 |
$24,257,422 |
| Total People Bought |
0 |
0 |
3 |
3 |
| Total Buy Transactions |
0 |
0 |
5 |
7 |
| Total Shares Sold |
27,731 |
27,731 |
42,731 |
43,589 |
| Total Sell Value |
$3,499,041 |
$3,499,041 |
$5,099,841 |
$5,194,152 |
| Total People Sold |
7 |
7 |
7 |
7 |
| Total Sell Transactions |
7 |
7 |
8 |
9 |
| End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Price Ben Gil |
Director |
– • – |
2013-08-19 |
4 |
B |
$31.18 |
$15,588 |
D/D |
500 |
35,330 |
2.39 |
- |
|
| Chase Anthony R |
Director |
– • – |
2013-06-14 |
4 |
B |
$38.50 |
$385,043 |
D/D |
10,000 |
28,244 |
2.39 |
- |
|
| Hodgman John |
Director |
– • – |
2013-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
4,333 |
|
- |
|
| Goolsbee William Alden |
Director |
– • – |
2013-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
5,166 |
|
- |
|
| Chase Anthony R |
Director |
– • – |
2013-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
18,244 |
|
- |
|
| Wigzell Hans Lennart Rudolf |
Director |
– • – |
2013-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
2,666 |
|
- |
|
| Price Ben Gil |
Director |
– • – |
2013-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
34,830 |
|
- |
|
| Behrens M Kathleen |
Director |
– • – |
2013-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
37,666 |
|
- |
|
| Aphale Jayant |
SVP, Technical OperationsOffic |
• – – |
2013-04-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
24,433 |
|
- |
|
| Chase Anthony R |
Director |
– • – |
2012-11-28 |
4 |
S |
$28.17 |
$262,689 |
D/D |
(8,900) |
17,244 |
|
- |
|
| Chase Anthony R |
Director |
– • – |
2012-11-27 |
4 |
S |
$29.04 |
$31,940 |
D/D |
(1,100) |
26,144 |
|
- |
|
| Chase Anthony R |
Director |
– • – |
2012-11-14 |
4 |
S |
$25.65 |
$257,002 |
D/D |
(10,000) |
27,244 |
|
- |
|
| Behrens M Kathleen |
Director |
– • – |
2012-09-07 |
4 |
B |
$14.58 |
$257,724 |
D/D |
17,500 |
36,666 |
2.39 |
- |
|
| Chase Anthony R |
Director |
– • – |
2012-09-07 |
4 |
S |
$13.95 |
$476,959 |
D/D |
(33,000) |
37,244 |
|
- |
|
| Goolsbee William Alden |
Director |
– • – |
2012-08-23 |
4 |
A |
$0.00 |
$0 |
D/D |
833 |
4,166 |
|
- |
|
| Wigzell Hans Lennart Rudolf |
Director |
– • – |
2012-08-23 |
4 |
A |
$0.00 |
$0 |
D/D |
833 |
1,666 |
|
- |
|
| Behrens M Kathleen |
Director |
– • – |
2012-08-23 |
4 |
A |
$0.00 |
$0 |
D/D |
833 |
19,166 |
|
- |
|
| Price Ben Gil |
Director |
– • – |
2012-08-23 |
4 |
A |
$0.00 |
$0 |
D/D |
833 |
33,830 |
|
- |
|
| Hodgman John |
Director |
– • – |
2012-08-23 |
4 |
A |
$0.00 |
$0 |
D/D |
833 |
3,333 |
|
- |
|
| Chase Anthony R |
Director |
– • – |
2012-08-23 |
4 |
A |
$0.00 |
$0 |
D/D |
833 |
70,244 |
|
- |
|
| Jacobsen Michael A |
VP of Finance and PAO |
• – – |
2012-08-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
7,500 |
|
- |
|
| Christopher Nishan Garabedian |
President and CEO |
• • – |
2012-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
81,666 |
511,666 |
|
- |
|
| Price Ben Gil |
Director |
– • – |
2012-03-14 |
4 |
B |
$1.30 |
$38,850 |
D/D |
30,000 |
197,982 |
2.39 |
- |
|
| Christopher Nishan Garabedian |
President and CEO |
• • – |
2011-12-15 |
4 |
B |
$0.58 |
$173,640 |
D/D |
300,000 |
430,000 |
2.81 |
- |
|
| Chase Anthony R |
Director |
– • – |
2011-09-13 |
4 |
B |
$1.20 |
$24,000 |
D/D |
20,000 |
416,467 |
2.39 |
- |
|
524 Records found
|
|
Page 16 of 21 |
|
|
3.67 (2.89%) 
